Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit Review0649 has been discontinued.
View all Adrenergic β<sub>1</sub> Receptors products.(S)-Timolol maleate is an β1-adrenergic blocker.
分子量 | 432.49 |
公式 | C13H24N4O3S.C4H4O4 |
储存 | Store at RT |
CAS Number | 26921-17-5 |
PubChem ID | 5281056 |
InChI Key | WLRMANUAADYWEA-NWASOUNVSA-N |
Smiles | [H]OC(=O)\C=C/C(=O)O[H].CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 |
上方提供的技术数据仅供参考。批次相关数据请参见分析证书。
Tocris products are intended for laboratory research use only, unless stated otherwise.
参考文献是支持产品生物活性的出版物。
Karhuvaara et al (1989) β-Adrenoceptor antagonist activities and binding affinities of tim. enantiomers in rat atria. J.Pharm.Pharmacol. 41 649 PMID: 2573714
Merck Index 12 9585
关键词: (S)-Timolol maleate, (S)-Timolol maleate supplier, α1-adrenoceptor, beta1-adrenoceptor, b1-adrenoceptor, β1-Adrenergic, beta1-Adrenergic, b1-adrenergic, antagonists, receptors, β-blockers, beta-blockers, Adrenergic, Beta-1, Receptors, 0649, Tocris Bioscience
引用文献是使用了 Tocris 产品的出版物。 (S)-Timolol maleate 的部分引用包括:
Xiao et al (2019) Acute tobacco smoke exposure exacerbates the inflammatory response to corneal wounds in mice via the sympathetic nervous system. Commun Biol 2 33 PMID: 30701198
目前没有该产品的评论。 Be the first to review (S)-Timolol maleate and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。
Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.